|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
AstraZeneca demonstrates strengths in haematology with robust data at ASH 2020 |
|||||||||||
|
|
|||||||||||
|
19 November 2020
AstraZeneca will present new research aimed at addressing key unmet needs facing patients with blood cancers at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, held virtually from 5 to 8 December 2020. |
|||||||||||
|